Navigation Links
Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
Date:2/29/2012

THE WOODLANDS, Texas, Feb. 29, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the Cowen and Company 32nd Annual Health Care Conference in Boston on Monday, March 5, 2012, at 3:30 p.m. Eastern Time.  Dr. Sands will provide an overview on Lexicon's clinical development programs and milestones.

A live webcast of the presentation will be available through Lexicon's corporate website at www.lexpharma.com.  An archived version of the presentation will be available for 30 days after the event.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statem
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
2. Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
3. Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
4. Lexicon Announces Commencement of Rights Offering to Stockholders
5. Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
6. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
7. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
8. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
9. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
10. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
11. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Sorrento Therapeutics, Inc. ... Fast-Track Advanced Technology Small Business Technology Transfer Research ... Allergy and Infectious Diseases (NIAID), a division of ... development of novel human antibody therapeutics to combat ... or Staph) infections, including methicillin-resistant S. aureus ...
(Date:5/17/2013)... SAN DIEGO and CAMBRIDGE, Mass., May 17, 2013 ... announce that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: ... District Court for the District of Massachusetts ... of its officers violated the Securities Exchange Act of ... May 1, 2013 (the "Class Period"). (Logo: ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- United Medical Education, a company that ... Pediatric Advanced Life Support (PALS) and Basic Life Support ... ACLS online course manuals. In order to gain ... build an account with the company. By offering the ... Medical Education is setting a precedent among similar companies. ...
Breaking Medicine Technology:Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2
... WIRE)--Apr 13, 2007 - Ascenta Therapeutics,Inc. announced today ... be featured in three oral,presentations and several poster ... American Association for Cancer Research,(AACR), to be held ... MDM2 program has been selected for presentation at ...
... /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. , a global, pure ... today announced that it,will present two abstracts outlining ... well as in vivo data on its GHRH ... for the treatment of cancer. These abstracts will ...
Cached Medicine Technology:Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 2Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 3Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 4Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 5Ascenta Therapeutics Highlights Multiple Data Presentations at,Upcoming AACR Annual Meeting 6AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 2AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 3
(Date:5/19/2013)... (PRWEB) May 19, 2013 According to a ... Firmers” many people are self-conscious about the appearance of certain ... option when diet and exercise fail to tone and tighten ... appeal to those looking to get the firmest body ... an effective mini-overview,” says Dr. Simon Ourian, Medical Director of ...
(Date:5/19/2013)... People in Minnesota have a great option to ... its 28 Day Fat Loss Formula. The best part ... their own home. The product sells for $135 dollars and ... accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost ... but after using the 28 Day Fat Loss Formula they ...
(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...
(Date:5/19/2013)... According to a new market ... (2013 – 2018): By Applications (Healthcare (Endoscopy, Radiology, ... CMOS, Contact IS, Infrared, X-Ray) And Geography" published ... was $8.00 billion in 2012 and is expected ... estimated CAGR of 3.84% from 2013 to 2018. ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The report ... Global Trends & Forecasts up to 2017” published by ... market with analysis and forecasting of the global volume ... identifies the driving and restraining factors for the global ... imperatives, and challenges. The market is segmented and revenue ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3
... Structured as a Social Business Enterprise, Facility Can ... Cataract Operations Annually, DHAKA, Bangladesh, May 2 ... to perform 50,000 eye examinations and,10,000 cataract operations ... laureate Professor Muhammad Yunus and the Hon,ble Adviser, ...
... New York, NYHealth insurance coverage and unpaid health care ... coverage costs the U.S. public $45 billion a year, ... today. This includes $33 billion in the cost of ... Health Insurance Program, and $12 billion in uncompensated care ...
... Approval Ratings Consistent with Public,s Support of ,Medicare for ... All, or Single-payer Healthcare, ... enact healthcare reform surfacing in Sacramento, a new field poll,this week ... of the California Nurses Association and registered,nurses., A poll this ...
... -- Beginning this Mother,s,Day, women across America will ... shows that when women take care of themselves, ... of this nationwide,initiative and to celebrate the launch ... the five minute daily solution for your smile ...
... PET Registry (NOPR) Study Showcases the Need to,Expand ... Cancer Treatment, WASHINGTON, May 1 US ... treatment and research networks,representing approximately 1,200 oncologists nationwide, ... Clinical Oncology (JCO) that,demonstrates the value of positron ...
... is available in French . , , ... Health Centre (MUHC) have performed the worlds first ... the new system developed by the researchers administers ... effects completely automatically, with no manual intervention. , ...
Cached Medicine News:Health News:Professor Muhammad Yunus and The Green Children to Open First Grameen Eye Hospital in Bangladesh on May 12, 2008 2Health News:Professor Muhammad Yunus and The Green Children to Open First Grameen Eye Hospital in Bangladesh on May 12, 2008 3Health News:$45 billion a year is spent by public on health costs for full-time workers and families 2Health News:$45 billion a year is spent by public on health costs for full-time workers and families 3Health News:$45 billion a year is spent by public on health costs for full-time workers and families 4Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 2Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 3Health News:Protect Yourself From Teeth to Toes! Lindsay Price and Crest Whitestrips Daily Whitening + Tartar Protection Partner to Empower Women for the 9th Annual National Women's Health Week 2Health News:Protect Yourself From Teeth to Toes! Lindsay Price and Crest Whitestrips Daily Whitening + Tartar Protection Partner to Empower Women for the 9th Annual National Women's Health Week 3Health News:US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies 2Health News:US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies 3Health News:World first: researchers develop completely automated anesthesia system 2
... Thrombosis now has new ... transformation of complex algorithms ... images into dynamic step-by-step ... precise, up-to-date information for ...
... enable all those involved with healthcare decisions ... very latest evidence in their field of ... each year as the volume of evidence ... delivering the best single source available for ...
Cardiology Intensive Board Review is geared specifically to candidates taking the Cardiovascular Boards and the Cardiovascular section of the Internal Medicine Boards....
... AHA Clinical Cardiac Consult is the ... guidance on the diagnosis and management ... abnormalities. From evaluation of chest pain ... congenital disease, this quick reference makes ...
Medicine Products: